Suppr超能文献

贝思伦肌病和乌尔里希先天性肌营养不良患者的身体成分、肌肉力量和身体功能

Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.

作者信息

Miscione Maria Teresa, Bruno Francesca, Ripamonti Claudio, Nervuti Giuliana, Orsini Riccardo, Faldini Cesare, Pellegrini Massimo, Cocchi Daniela, Merlini Luciano

机构信息

Department of Orthopaedics, Istituto Ortopedico Rizzoli, IRCCS, 40136 Bologna, Italy.

出版信息

ScientificWorldJournal. 2013 Sep 12;2013:152684. doi: 10.1155/2013/152684. eCollection 2013.

Abstract

OBJECTIVE

To determine the contributions of body mass, adiposity, and muscularity to physical function and muscle strength in adult patients with Bethlem myopathy (BM) and Ullrich congenital muscular dystrophy (UCMD).

MATERIALS AND METHODS

Evaluation involved one UCMD and 7 BM patients. Body composition was determined by body mass index (BMI) and dual-energy-X-ray-absorptiometry (DXA), muscle strength by dynamometry, physical function by the distance walked in 6 minutes (6MWD), forced vital capacity (FVC) by a spirometer.

RESULTS

Six participants were of normal weight and 2 overweight based on BMI; all were sarcopenic based on appendicular fat free mass index (AFFMI); and 7 were sarcopenic obese based on AFFMI and % fat mass. Average muscle strength was reduced below 50% of normal. The 6MWD was in BM patients 30% less than normal. FVC was reduced in 4 of the BM patients. Muscle strength had a good correlation with the physical function variables. Correlation between muscle strength and BMI was poor; it was very high with AFFMI. AFFMI was the best single explicator of muscle strength and physical function.

CONCLUSION

Muscle mass determined by DXA explains most of the variability of the measures of muscle strength and physical function in patients with BM and UCMD.

摘要

目的

确定体重、肥胖程度和肌肉量对贝思伦肌病(BM)和乌尔里希先天性肌营养不良(UCMD)成年患者身体功能和肌肉力量的影响。

材料与方法

评估涉及1例UCMD患者和7例BM患者。通过体重指数(BMI)和双能X线吸收法(DXA)测定身体成分,通过握力计测定肌肉力量,通过6分钟步行距离(6MWD)评估身体功能,通过肺活量计测定用力肺活量(FVC)。

结果

根据BMI,6名参与者体重正常,2名超重;根据四肢无脂肪质量指数(AFFMI),所有参与者均存在肌肉减少症;根据AFFMI和体脂百分比,7名参与者存在肌肉减少性肥胖。平均肌肉力量降低至正常水平的50%以下。BM患者的6MWD比正常水平低30%。4例BM患者的FVC降低。肌肉力量与身体功能变量具有良好的相关性。肌肉力量与BMI的相关性较差;与AFFMI的相关性非常高。AFFMI是肌肉力量和身体功能的最佳单一解释指标。

结论

通过DXA测定的肌肉量解释了BM和UCMD患者肌肉力量和身体功能测量指标的大部分变异性。

相似文献

1
Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.
ScientificWorldJournal. 2013 Sep 12;2013:152684. doi: 10.1155/2013/152684. eCollection 2013.
2
Muscle proteomics reveals novel insights into the pathophysiological mechanisms of collagen VI myopathies.
J Proteome Res. 2014 Nov 7;13(11):5022-30. doi: 10.1021/pr500675e. Epub 2014 Sep 24.
3
Clinical features of collagen VI-related dystrophies: A large Brazilian cohort.
Clin Neurol Neurosurg. 2020 May;192:105734. doi: 10.1016/j.clineuro.2020.105734. Epub 2020 Feb 10.
4
Nutritional status evaluation in patients affected by bethlem myopathy and ullrich congenital muscular dystrophy.
Front Aging Neurosci. 2014 Nov 17;6:315. doi: 10.3389/fnagi.2014.00315. eCollection 2014.
5
Autophagy activation in COL6 myopathic patients by a low-protein-diet pilot trial.
Autophagy. 2016 Dec;12(12):2484-2495. doi: 10.1080/15548627.2016.1231279. Epub 2016 Sep 22.
7
The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.
Handb Clin Neurol. 2011;101:81-96. doi: 10.1016/B978-0-08-045031-5.00005-0.
8
Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.
Front Aging Neurosci. 2014 Oct 7;6:274. doi: 10.3389/fnagi.2014.00274. eCollection 2014.
9
Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.
Neuromuscul Disord. 2019 Sep;29(9):657-663. doi: 10.1016/j.nmd.2019.07.007. Epub 2019 Jul 30.
10
Autosomal dominant Ullrich congenital muscular dystrophy due to a mutation in gene. A case report.
Acta Myol. 2022 Jun 30;41(2):95-98. doi: 10.36185/2532-1900-073. eCollection 2022 Jun.

引用本文的文献

1
Pregnancy in a woman with extreme short stature and low body weight secondary to a collagen VI-related muscular dystrophy.
Obstet Med. 2025 Jun;18(2):123-126. doi: 10.1177/1753495X231219298. Epub 2023 Dec 21.
3
Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy.
Front Physiol. 2020 Aug 12;11:1008. doi: 10.3389/fphys.2020.01008. eCollection 2020.
5
Nutritional status evaluation in patients affected by bethlem myopathy and ullrich congenital muscular dystrophy.
Front Aging Neurosci. 2014 Nov 17;6:315. doi: 10.3389/fnagi.2014.00315. eCollection 2014.

本文引用的文献

1
Rapidly progressive scoliosis and respiratory deterioration in Ullrich congenital muscular dystrophy.
J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):982-8. doi: 10.1136/jnnp-2012-304710. Epub 2013 Apr 9.
2
Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.
Orphanet J Rare Dis. 2013 Feb 14;8:26. doi: 10.1186/1750-1172-8-26.
3
Reference equations for the performance of healthy adults on field walking tests.
J Bras Pneumol. 2011 Sep-Oct;37(5):607-14. doi: 10.1590/s1806-37132011000500007.
4
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results.
Oxid Med Cell Longev. 2011;2011:139194. doi: 10.1155/2011/139194. Epub 2011 Oct 17.
6
Regional body composition and functional impairment in patients with myotonic dystrophy.
Muscle Nerve. 2011 Oct;44(4):503-8. doi: 10.1002/mus.22099. Epub 2011 Aug 8.
7
Decreased bone mineral density in adult patients with muscular dystrophy.
Joint Bone Spine. 2011 Dec;78(6):651-2. doi: 10.1016/j.jbspin.2011.05.006. Epub 2011 Jul 2.
8
Sarcopenia: designing phase IIB trials.
J Nutr Health Aging. 2011 Jun;15(6):450-5. doi: 10.1007/s12603-011-0092-7.
9
Autophagy induction rescues muscular dystrophy.
Autophagy. 2011 Apr;7(4):426-8. doi: 10.4161/auto.7.4.14392.
10
The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.
Handb Clin Neurol. 2011;101:81-96. doi: 10.1016/B978-0-08-045031-5.00005-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验